This episode is for you.

In this episode, Dr. Rebbecca Hertel discusses the significant removal of the black box warning from systemic hormone therapy, a change that marks a pivotal moment in women's health. The conversation delves into the implications of this decision, the historical context surrounding the Women's Health Initiative, and the need for updated education for both clinicians and patients. Dr. Hertel emphasizes the importance of informed discussions about hormone therapy, the ongoing need for clinician training, and the empowerment of women to make educated choices regarding their health.

Takeaways

• The FDA has removed the black box warning from systemic hormone therapy.
• This change is a significant correction in women's health.
• Women have suffered due to outdated warnings and misinformation.
• The Women's Health Initiative played a crucial role in shaping perceptions of hormone therapy.
• Removing the black box warning allows for evidence-based discussions about hormone therapy.
• Clinicians need updated education on hormone therapy and its benefits.
• Women deserve informed conversations about their health options.
• The removal of the warning does not mean hormones are risk-free.
• There is a need for nuanced discussions in women's health care.
• Empowering women with accurate information can lead to better health outcomes.

Work With Dr. Rebbecca

If you want personalized support for perimenopause, menopause, metabolism, hormones, sleep, and midlife care:

🌐 OsteopathicMidlifeHealth.com 📩 Book a consultation

📰 Join the Midlife Minute Newsletter

📱 Follow on Instagram, LinkedIn, Facebook 🎧

Clinicians: Listen on Pinnacle for CME

Support the Show

👍 Like 🔔 Subscribe ⭐ Rate & Review 📤 Share this episode with a friend who needs midlife science & sanity

Your reviews help women find evidence-based support in a world that still underestimates midlife.